Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA‐LEA noninterventional studies by Sylvia Haas, Lorenzo G. Mantovani, Reinhold Kreutz, Danja Monje, Jonas Schneider, Elizabeth R. Zell, Miriam Tamm, Martin Gebel, Jörg‐Peter Bugge, Walter Ageno, Alexander G. G. Turpie

Get full text

Risk of recurrent venous thromboembolism according to baseline risk factor profiles by Martin H. Prins, Anthonie W.A. Lensing, Paolo Prandoni, Philip S. Wells, Peter Verhamme, Jan Beyer-Westendorf, Rupert Bauersachs, Henri Bounameaux, Timothy A. Brighton, Alexander T. Cohen, Bruce L. Davidson, Hervé Decousus, Ajay K. Kakkar, Bonno van Bellen, Akos F. Pap, Martin Homering, Miriam Tamm, Jeffrey I. Weitz

Get full text

Participant Engagement and Preference Study for Clinical Outcomes Associated With Atrial Fibrillation by Shelby D. Reed, PhD, Josephine L. Harrington, MD, Daniel P. Morin, MD, MPH, Samir F. Saba, MD, Jay Alan Montgomery, MD, Robert W. Harrison, MD, Daniel R. Frisch, MD, Thomas Viethen, MD, Miriam Tamm, PhD, Jessica Xiao, PharmD, Hardi Mundl, MD, Rosa Coppolecchia, DO, MPH, Jui-Chen Yang, MEM, Matthew J. Wallace, MA, Juan Marcos Gonzalez, PhD, Manesh R. Patel, MD

Get full text